HGF and metabolic dysfunction-associated steatotic liver disease: The present work investigated novel mechanisms underlying AICAR mitigation of NAFLD-associated oxido-inflammatory damage by modulating HGF/NF-κB signaling, regulating ER stress and mitochondrial dysfunction, and restoring metabolic homeostasis regardless of AMPK dependence.